<img alt="" src="https://secure.soil5hear.com/223550.png" style="display:none;">
Skip to content





Always at the forefront of the dynamic patient-derived xenograft (PDX) market, Champions Oncology has emerged as a respected key opinion leader on the utilization and benefits of PDX models in oncology drug development.

Clinical Flow Cytometry
Hematological Malignancies
Humanized Models
Lumin Acuity
Solid Tumor PDX Models
TumorGraft3D & Co-Culture Platforms